GB963427A - 16-methylene-17ª -acetoxy-progesterone-derivatives and the preparation thereof - Google Patents

16-methylene-17ª -acetoxy-progesterone-derivatives and the preparation thereof

Info

Publication number
GB963427A
GB963427A GB26066/61D GB2606661D GB963427A GB 963427 A GB963427 A GB 963427A GB 26066/61 D GB26066/61 D GB 26066/61D GB 2606661 D GB2606661 D GB 2606661D GB 963427 A GB963427 A GB 963427A
Authority
GB
United Kingdom
Prior art keywords
general formula
treating
steroid
microorganisms
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB26066/61D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Merck AG filed Critical E Merck AG
Publication of GB963427A publication Critical patent/GB963427A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

963,427. Steroids. E. MERCK A.G. Jan. 23, 1961 [Jan. 30, 1960], No. 2606/61. Heading C2U. The invention comprises steroids of the general formula: wherein X represents hydrogen, fluorine or chlorine or the methyl group, R represents hydrogen or a hydroxy group (R represents OH when Y represents fluorine), and the corresponding #<SP>1-</SP>, # <SP>6</SP>- and #<SP>1</SP>, <SP>6</SP>-derivatives thereof, and the preparation thereof by treating 16- methylene -17α- acetoxy-progesterones of the general formula: wherein R, X and Y have the above significance, with chloranil to form the corresponding 6- dehydro-compound and/or dehydrogenating at the 1,2-positions by treating with 2,3-dichloro-5, 6-dicyano-benzoquinone, selenium dioxide or 1,2-dehydrogenating microorganisms, by treating a 9#, 11#-oxido compound of the general formula: wherein X has the above significance, or the corresponding 1, 2 and/or 6, 7 unsaturated compound, with hydrogen fluoride, by treating a steroid of the general formula: wherein X has the above significance and R 1 represents hydrogen or acyl and a bromine atom may be attached to C 5 in which case the 5,6-position is saturated if X is fluorine, with a chemical or microbiological oxidising agent such as a mixture of a ketone and an aluminium alcoholate chromic acid, potassium dichromate or N-bromo-succinimide or the oxygenating activity produced by growing Flavobacterium dehydrogenans microorganisms or microorganisms of the genus Aspergillus, Bacillus, Corynebacterium, Ermothecium, Mycobacterium, Penicillium, Phycomyces, Pseudomonas, Steptomyces or Ustilago and by treating steroids of the general formula: wherein X has the above significance, or a corresponding 1,2 and/or 6,7-unsaturated compound, with an acetylating agent. Suitable microorganisms which may be used for 1,2-dehydrogenation are of the genus Alternaria, Didymella, Calonectria, Colletotrichum; Cylindrocarpon, Fusarium, Ophiobolus, Septomyxa, Vermicularia, Acetobacter, Aerobacter, Alcaligenes, Bacillus, Corynebacterium, Erysipelothrix, Fusarium, Listeria, Micromonospora, Mycobacterium, Nocardia, Protaminobacter, Pseudomonas and Steptomyces. Particularly suitable 1,2-dehydrogenating microorganisms are Bacillus sphaericus var. fusiformis, Corynebacterium simplex and Fusarium solani. It is possible to use more than one of the above processes to prepare a steroid of the first general formula above. In addition, a steroid prepared by the last process above may be subsequently 11-hydroxylated, then dehydrated to form the 9,11-dehydro derivative, epoxised to form the 9 #, 11 #-oxido-steroid and then treated with hydrogen fluoride to form the 9α-fluoro-11#-hydroxy-compound. 16-Methylene-steroids of the previous four general formulae above are prepared from the corresponding 16#-methyl-16α, 17α-oxidosteroids by treatment with at least catalytic quantities of a strong acid and may be acetylated as required. Pharmaceutical compositions having progesterone type activity and which may be administered as pills, tablets, dragees, suppositories, emulsions, suspensions or injectable solutions contain as the active ingredient steroid compounds of the first general formula above. Specifications 857,114, 858,033 and 941,553 are referred to.
GB26066/61D 1960-01-30 1961-01-23 16-methylene-17ª -acetoxy-progesterone-derivatives and the preparation thereof Expired GB963427A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM44160A DE1174314B (en) 1960-01-30 1960-01-30 Process for the preparation of 16-methylene-9ª-fluoro-11ª-hydroxy-17ª-acetoxy-progesterone derivatives

Publications (1)

Publication Number Publication Date
GB963427A true GB963427A (en) 1964-07-08

Family

ID=7304892

Family Applications (1)

Application Number Title Priority Date Filing Date
GB26066/61D Expired GB963427A (en) 1960-01-30 1961-01-23 16-methylene-17ª -acetoxy-progesterone-derivatives and the preparation thereof

Country Status (7)

Country Link
BR (1) BR6125904D0 (en)
CH (4) CH393317A (en)
DE (4) DE1176134B (en)
DK (1) DK115180B (en)
FR (1) FR881M (en)
GB (1) GB963427A (en)
SE (3) SE310675B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2865808A (en) * 1958-06-09 1958-12-23 Pfizer & Co C 16-methylene pregnene derivatives

Also Published As

Publication number Publication date
DE1174314B (en) 1964-07-23
DE1176133B (en) 1964-08-20
DE1176134B (en) 1964-08-20
DE1176132B (en) 1964-08-20
FR881M (en) 1961-10-23
CH393316A (en) 1965-06-15
DK115180B (en) 1969-09-15
SE310675B (en) 1969-05-12
BR6125904D0 (en) 1973-05-29
CH393317A (en) 1965-06-15
CH395081A (en) 1965-07-15
SE302123B (en) 1968-07-08
CH395082A (en) 1965-07-15
SE301800B (en) 1968-06-24

Similar Documents

Publication Publication Date Title
US2837464A (en) Process for production of dienes by corynebacteria
US3684657A (en) Selective microbiological degradation of steroidal 17-alkyls
US3134718A (en) Pregna-1,4-dienes and compositions containing same
US2880205A (en) 6-fluoro-9alpha-halo-11-oxygenated-4-pregnenes and 6-fluoro-9alpha-halo-11-oxygenated-, 4-pregnadienes
US2776927A (en) Preparation of delta 1, 4-3-keto steroids from delta4 3-keto steroids by protaminobacter
GB963427A (en) 16-methylene-17ª -acetoxy-progesterone-derivatives and the preparation thereof
Casas-Campillo et al. STEROIDS CLIX: Antimicrobial Properties of 21, 22-Dimethoxy Progesterone and other progesterone analogues
US2867630A (en) 6-fluoro androstenes
US2877240A (en) 6-fluoro-17beta-hydroxy-17alpha-lower aliphatic hydrocarbon-1, 4-androstadienes and 6-fluoro-17alpha-lower aliphatic hydrocarbon estradiols
US3360439A (en) Process for preparing 1-dehydro steroids
US2838546A (en) 6 alpha-fluoro-16 alpha-hydroxy-1, 4-pregnadienes
Charney et al. Microbiological transformation of steroids—XI: the action of corynebacterium simplex on non-corticoid steroid substrates
US3065146A (en) Process for preparing 9alpha-hydroxy steroids
US3080298A (en) Method of 9alpha-hydroxylating steroids
US3045031A (en) 6alpha-methyl-9alpha-fluoro-11-oxygenated progesterones
US2876219A (en) 6-fluoro-9alpha-halo-11-oxygenated-4-pregnenes and 6-fluoro-9alpha-halo-11-oxygenated-1,4-pregnadienes
Lin et al. Microbial hydroxylations. IV. Differential metabolism of 19-norsteroid antipodes by Curvularia lunata
US2992973A (en) Dehydrogenation of steroids by azotobacter microorganisms
US3239540A (en) 1-dehydro-6-fluoroprogesterones
US3419470A (en) 11-microbiological hydroxylation of steroids in presence of dimethylsulfoxide
US3054811A (en) Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series
US2914543A (en) Synthesis of steroids
US3004044A (en) 1-dehydro-6-fluoro-11-oxygenated progesterones
US3010876A (en) Oxidation of steroid compounds in presence of antibiotics
US3665022A (en) Degradation of side chain in sapogenins